Evidence Repository - GENBOREE REDMINE

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.2(PAH):c.355C>T (p.Pro119Ser)

Curation History

CA220582

92741 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 38a183ee-7e53-4c24-a250-50958f390c78

Approved on: 2018-07-29

Published on: 2019-04-06

HGVS expressions

NM_000277.2:c.355C>T

NM_000277.2(PAH):c.355C>T (p.Pro119Ser)

NC_000012.12:g.102877548G>A

CM000674.2:g.102877548G>A

NC_000012.11:g.103271326G>A

CM000674.1:g.103271326G>A

NC_000012.10:g.101795456G>A

NG_008690.1:g.45055C>T

NG_008690.2:g.85863C>T

NM_000277.1:c.355C>T

NM_001354304.1:c.355C>T

NM_000277.3:c.355C>T

ENST00000307000.7:c.340C>T

ENST00000549111.5:n.451C>T

ENST00000550978.6:n.339C>T

ENST00000551337.5:c.355C>T

ENST00000551988.5:n.444C>T

ENST00000553106.5:c.355C>T

Likely Pathogenic

PP3 PM3_Strong PP4_Moderate

PM2

Evidence Links 2

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

PAH-specific ACMG/AMP criteria applied: PP3: in silico analysis supportive of damaging effect; PM3_Strong: In trans with R261Q (PMID 21147011), and in trans with IVS2+1G>A (PMID 12655554) (PMID:21147011; PMID:12655554); PP4_Moderate: BH4 deficiency excluded (PMID:21147011). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PP3, PM3_Strong, PP4_Moderate).

PP3

in silico analysis supportive of damaging effect

PM3_Strong

In trans with R261Q (PMID 21147011), and in trans with IVS2+1G>A (PMID 12655554)

in trans with IVS2+1G>A PubMed:12655554

in trans with R261Q PubMed:21147011

PP4_Moderate

BH4 deficiency excluded

BH4 defect excluded at NBS and by sequencing of BH4 associated genes PubMed:21147011

PM2

PAH specific specifications state PM2 criteria as 0.02% (AF=0.0002)

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.